BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, December 20, 2025
Home » Topics » Briefs » Appointments and advancements

Appointments and advancements
Appointments and advancements RSS Feed RSS

Appointments and advancements for Oct. 5, 2020

Oct. 5, 2020
New hires and promotions in the med-tech industry, including: Neuronetics, Northstar Medical Technologies, Pq Bypass.
Read More

Appointments and advancements for Oct. 5, 2020

Oct. 5, 2020
New hires and promotions in the biopharma industry, including: Allena, Biomarin, CGT Catapult, Expansion, Genomics, Immunophotonics, Intellia, Medivir, Opthea, Oxular, Proqr, Q-State, Reven.
Read More

Appointments and advancements for Oct. 2, 2020

Oct. 2, 2020
New hires and promotions in the med-tech industry, including: Choicespine, Delcath, Micron Medical, Silk Road.
Read More

Appointments and advancements for Oct. 2, 2020

Oct. 2, 2020
New hires and promotions in the biopharma industry, including: Delcath, Elucida, Intra-Cellular Therapies, Merck, Plus.
Read More

Appointments and advancements for Oct. 1, 2020

Oct. 1, 2020
New hires and promotions in the med-tech industry, including: Axogen, Cantel Medical, Centricity Vision, Healthmap, Ibex, MDIC.
Read More

Appointments and advancements for Oct. 1, 2020

Oct. 1, 2020
New hires and promotions in the biopharma industry, including: Acadia, Adamas, Akouos, Aztherapies, Boehringer Ingelheim, Cara, G1, Hyloris, Insitro, Kaleido, Khondrion, Korro, Lipidor, Medicenna, Puretech, Sage, Tarveda, Vico, X4.
Read More

Appointments and advancements for Sept. 30, 2020

Sep. 30, 2020
New hires and promotions in the med-tech industry, including: Doc.ai, Sema4, Thrive Earlier Detection.
Read More

Appointments and advancements for Sept. 30, 2020

Sep. 30, 2020
New hires and promotions in the biopharma industry, including: Compugen, Numab, Qihan.
Read More

Appointments and advancements for Sept. 29, 2020

Sep. 29, 2020
New hires and promotions in the biopharma industry in Asia-Pacific, including: Sichuan Clover Biopharmaceuticals.
Read More

Appointments and advancements for Sept. 29, 2020

Sep. 29, 2020
New hires and promotions in the med-tech industry, including: Aziyo, Bioaffinity Technologies, Cyted, Deep Genomics, Exthera, Madaket, Omniome, Orb Health, Prometheus Biosciences, Solutionreach, Theralink Technologies.
Read More
Previous 1 2 … 260 261 262 263 264 265 266 267 268 … 310 311 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 19, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 19, 2025.
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing